Jacek Wójcikowski

2.1k total citations
73 papers, 1.6k citations indexed

About

Jacek Wójcikowski is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jacek Wójcikowski has authored 73 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pharmacology, 25 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in Jacek Wójcikowski's work include Pharmacogenetics and Drug Metabolism (43 papers), Neuroscience and Neuropharmacology Research (18 papers) and Drug Transport and Resistance Mechanisms (16 papers). Jacek Wójcikowski is often cited by papers focused on Pharmacogenetics and Drug Metabolism (43 papers), Neuroscience and Neuropharmacology Research (18 papers) and Drug Transport and Resistance Mechanisms (16 papers). Jacek Wójcikowski collaborates with scholars based in Poland, United States and France. Jacek Wójcikowski's co-authors include Władysława A. Daniel, Anna Haduch, Patrick Maurel, Krystyna Gołembiowska, Ewa Bromek, Zofia Rogóż, G Skuza, Marta Kot, Agnieszka Pałucha-Poniewiera and Dominika Dudek and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Jacek Wójcikowski

72 papers receiving 1.6k citations

Peers

Countries citing papers authored by Jacek Wójcikowski

Since Specialization

Citations

This map shows the geographic impact of Jacek Wójcikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Wójcikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Wójcikowski more than expected).

Fields of papers citing papers by Jacek Wójcikowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Wójcikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Wójcikowski. The network helps show where Jacek Wójcikowski may publish in the future.

Co-authorship network of co-authors of Jacek Wójcikowski

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Wójcikowski. A scholar is included among the top collaborators of Jacek Wójcikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Wójcikowski. Jacek Wójcikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy 2020 ·Toxicology and Applied Pharmacology ·(unknown), Jacek Wójcikowski, Władysława A. Daniel	10
2	1-Methyl-1,2,3,4-tetrahydroisoquinoline – The toxicological research on an exo/endogenous amine with antidepressant-like activity – In vivo, in vitro and in silico studies 2019 ·Pharmacological Reports ·(unknown), (unknown), Jacek Wójcikowski, (unknown)	1
3	Activation of 5-HT1A Receptors in the Hypothalamic Paraventricular Nuclei Negatively Regulates Cytochrome P450 Expression and Activity in Rat Liver 2018 ·Drug Metabolism and Disposition ·Ewa Bromek, (unknown), Anna Haduch, Jacek Wójcikowski, Władysława A. Daniel	11
4	N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties 2016 ·ACS Medicinal Chemistry Letters ·Paweł Zajdel, Krzysztof Marciniec, Grzegorz Satała, Vittorio Canale, Tomasz Kos, Anna Partyka, Magdalena Jastrzębska‐Więsek, Anna Wesołowska, (unknown), Jacek Wójcikowski, Władysława A. Daniel, Andrzej J. Bojarski, Piotr Popik	39
5	Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study 2015 ·Pharmacological Reports ·(unknown), Władysława A. Daniel, Jacek Wójcikowski	12
6	Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver 2013 ·Pharmacological Reports ·Jacek Wójcikowski, Anna Haduch, Władysława A. Daniel	24
7	The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: An in vitro study 2012 ·Pharmacological Research ·Anna Haduch, Ewa Bromek, Anna Sadakierska−Chudy, Jacek Wójcikowski, Władysława A. Daniel	33
8	Effect of classic and atypical neuroleptics on cytochrome P450 3A (CYP3A) in rat liver 2012 ·Pharmacological Reports ·Jacek Wójcikowski, Anna Haduch, Władysława A. Daniel	30
9	The Role of the Nervous System in the Regulation of Liver Cytochrome P450 2011 ·Current Drug Metabolism ·Jacek Wójcikowski, Władysława A. Daniel	38
10	Influence of antidepressant drugs on chlorpromazine metabolism in human liver -an in vitro study 2010 ·Pharmacological Reports ·Jacek Wójcikowski, Władysława A. Daniel	5
11	The brain dopaminergic system as an important center regulating liver cytochrome P450 in the rat 2009 ·Expert Opinion on Drug Metabolism & Toxicology ·Jacek Wójcikowski, Władysława A. Daniel	51
12	Regulation of liver cytochrome P450 by activation of brain dopaminergic system: Physiological and pharmacological implications 2008 ·Biochemical Pharmacology ·Jacek Wójcikowski, Krystyna Gołembiowska, Władysława A. Daniel	49
13	The Regulation of Liver Cytochrome P450 by the Brain Dopaminergic System 2007 ·Current Drug Metabolism ·Jacek Wójcikowski, Krystyna Gołembiowska, Władysława A. Daniel	39
14	Effect of chronic treatment with perazine on lipopolysaccharide-induced interleukin-1β levels in the rat brain 2006 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Ewa Obuchowicz, (unknown), Łukasz Drzyzga, Jacek Wójcikowski, Władysława A. Daniel, Zbigniew S. Herman	7
15	2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice 2005 ·Psychopharmacology ·Ewa Kozela, (unknown), Tomasz Kos, Jacek Wójcikowski, Władysława A. Daniel, Krystyna M. Wozniak, Barbara S. Slusher, Piotr Popik	14
16	Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo–possible involvement of different mechanisms 2004 ·European Neuropsychopharmacology ·Władysława A. Daniel, Anna Haduch, Jacek Wójcikowski	24
17	Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine. 1999 ·PubMed ·Władysława A. Daniel, (unknown), Anna Haduch, Jacek Wójcikowski	11
18	Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants 1999 ·European Neuropsychopharmacology ·Władysława A. Daniel, Jacek Wójcikowski	46
19	Interactions between Promazine and Antidepressants at the Level of Cellular Distribution 1997 ·Pharmacology & Toxicology ·Władysława A. Daniel, Jacek Wójcikowski	24
20	Effect of carbamazepine on the pharmacokinetics of promazine. 1996 ·PubMed ·(unknown), Jacek Wójcikowski, Władysława A. Daniel	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact